Search for a person, company, university, or list

Feed Explore Lists Jobs

Made with love by a16z

Privacy Terms Disclosure FAQ

Ask Cosign

Faeth Therapeutics | Cosign

Contents

1Overview 2Cosigns 3Team 4Jobs

Faeth Therapeutics

Faeth Therapeutics is pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway.

Industry: Biotechnology & Pharmaceuticals
Links

Unclaimed Profile: Created from public information and may contain inaccuracies. Work here? Request access to manage this profile. The Cosign team reviews each claim request.

Faeth Therapeutics develops oral cancer therapeutics designed to inhibit multiple nodes of the PAM pathway. The company was acquired by Sensei Biotherapeutics in February 2026.

Cosigns

Team

Jobs